Group Program vs Single-Session Depathologizing Intervention for Subthreshold Anxiety-Depression in Primary Care (Spain)
A Randomized Controlled Trial Comparing a Manualized Group Program (PADAP) Versus an Active Single-Session Depathologizing Intervention (SSDI) for Subthreshold Anxious-Depressive Symptoms in Primary Care in Spain
3 other identifiers
interventional
136
1 country
1
Brief Summary
This study evaluated two psychological interventions for adults with mild to moderate subthreshold anxious-depressive symptoms in primary care in Spain. Participants referred by general practitioners were randomly assigned to either (1) PADAP, a manualized transdiagnostic group program delivered in 10 weekly 90-minute sessions, or (2) a structured active single-session depathologizing intervention (SSDI), delivered individually in one 50-60-minute session. The primary aim was to compare changes in depressive and anxiety symptoms from baseline to 12 months. Secondary aims included comparing primary care mental health-related consultations, psychotropic medication use, new contacts with mental health services, and perceived need for further mental health care during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Feb 2021
Longer than P75 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 2, 2026
CompletedFirst Posted
Study publicly available on registry
January 23, 2026
CompletedJanuary 23, 2026
January 1, 2026
2.6 years
January 2, 2026
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Anxiety symptoms (STAI-State and STAI-Trait total scores)
State-Trait Anxiety Inventory (STAI), State and Trait subscales, total scores. Higher scores indicate greater anxiety symptom severity.
Baseline and 12 months
Depressive symptoms (BDI total score)
Beck Depression Inventory (BDI), total score. Higher scores indicate greater depressive symptom severity.
Baseline and 12 months
Secondary Outcomes (4)
GP mental health-related consultations (12 months pre vs 12 months post)
12 months before intervention and 12 months after intervention
Psychotropic medication use (yes/no)
Baseline and 12 months
New contact with mental health services (yes/no)
12 months
Perceived need for referral or additional care (yes/no)
12 months after intervention
Study Arms (2)
PADAP group program (10 sessions)
ACTIVE COMPARATORManualized, multimodal, transdiagnostic cognitive-behavioral group intervention delivered in 10 weekly sessions (90 minutes each) by trained clinical psychology residents. Modules cover emotions (psychoeducation), anxiety (physiological arousal management, cognitive restructuring, problem solving), sadness (behavioral activation), and anger (anger regulation and assertiveness training).
Single-session depathologizing intervention (SSDI)
ACTIVE COMPARATORStructured individual single-session intervention (50-60 minutes) delivered by trained clinical psychology residents. The session focuses on empathic listening, shared formulation, contextualization and normalization of distress, narrative reframing (challenging symptoms-as-disease explanations), and activation of personal and social resources outside the healthcare system.
Interventions
Manualized, multimodal, transdiagnostic cognitive-behavioral group intervention delivered in 10 weekly sessions (90 minutes each) by trained clinical psychology residents. Content includes psychoeducation about emotions; anxiety management (physiological arousal management, cognitive restructuring, problem solving); sadness management (behavioral activation, increasing positive reinforcement); and anger management (anger regulation and assertiveness training).
Structured individual single-session intervention (50-60 minutes) delivered by trained clinical psychologists/clinical psychology residents. The session focuses on empathic listening and shared formulation; contextualization and normalization of distress; de-pathologizing explanations by challenging symptoms-as-disease narratives; narrative reframing; and activation of personal and social resources outside the healthcare system.
Eligibility Criteria
You may qualify if:
- \. Referred from primary care by a general practitioner.
- \. Mild to moderate anxious-depressive symptoms based on the GP's clinical judgement during routine consultations, with or without psychotropic medication.
You may not qualify if:
- \. Receiving active mental health treatment (public or private).
- \. Current substance dependence (except nicotine).
- \. Organic, neurological, or cognitive disorder related to the symptoms.
- \. Language barriers that precluded participation or completion of assessments.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Príncipe de Asturias (recruitment from 4 primary care centres), Spain
Alcalá de Henares, Madrid, 28806, Spain
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego Sanchez Ruiz
University of Alcala
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessment at 12 months was performed by assessors blinded to group assignment. Participants and intervention providers were not blinded. Baseline assessment for the SSDI arm was conducted by the clinician delivering the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 2, 2026
First Posted
January 23, 2026
Study Start
February 1, 2021
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
January 23, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
The datasets generated and/or analysed during the current study are not publicly available due to the risk of compromising participant privacy and because they include information derived from electronic health records, but are available from the corresponding author on reasonable request and subject to approval by the relevant data controller/health service.